Voyageur Pharmaceuticals (TSE:VM) has released an update.
Voyageur Pharmaceuticals Ltd has announced signing a $1.9 million international distribution agreement for their SmoothX 2% barium contrast medium, marking their entry into the Latin American market. The agreement covers marketing and sales in two countries and involves the distributor managing regulatory approvals and commercialization. This deal is a significant step in Voyageur’s global expansion strategy and complements their upcoming suite of medical imaging products.
For further insights into TSE:VM stock, check out TipRanks’ Stock Analysis page.
